Search results for

For establishments based in NI a third country is defined as:

Assessment tool to demonstrate that imported tissues and cells meet equivalent standards of quality and safety to those required by the Human Tissue (Qua

The HTA-related licensing changes introduced at the end of the UK Transition Period affect some establishments that previously did not require an HTA licen...

The six-month phase for Human Application sector establishments to comply with new import and export licensing requirements ended on 1 July 2021.

Find out more about our Board, and other standing committees.

The Authority – the HTA’s non-executive board – is made up of a Chair and 11 Members who are appointed by the Secretary of State for Health, with the excep...

Throughout the year we host a programme of stakeholder engagement events.

The HTA Audit Committee is an advisory body to the Human Tissue Authority board (the Authority). The main functions of the Audit Committee are to:

The duties of the Remuneration Committee are to:

The HTA has a responsibility to make its information available in accordance with the Freedom of Information Act. Before making a Freedom of Informa

You can browse and read previous FOI responses below.

Under the Enterprise Act 2016, the HTA and all other statutory regulators have a duty to report against the Government’s Business Impact Target.

HTA licensed establishments in the Post-mortem sector are required to report incidents to the HTA - we call these HTARIs - and those in the Human Applica